ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
FDA Strengthens Black Box Warning for Singulair, All Montelukast Generics americanpharmaceuticalreview
March 06, 2020The U.S. Food and Drug Administration (FDA) is strengthening existing warnings about serious behavior and mood-related changes with montelukast (Singulair and generics) ... -
FDA Announces Voluntary Recall of Montelukast
americanpharmaceuticalreview
September 05, 2018The U.S. Food and Drug Administration (FDA) is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Piscataway, N.J.
Pharma Sources Insight January 2025
